JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Cloudera, Inc. (CLDR) Reports 12M Common Stock Offering, Including 9M for Selling Stockholders
-
Cloudera Announces Launch of Proposed Follow-on Offering
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $140 at JMP Securities; Sees Minimal to Modest Sales Impact
-
Neovasc (NVCN) Court Documents Suggest a Major Catalyst is Forthcoming, Possibly a Sale - JMP Securities
-
First Solar (FSLR) to Benefit from Section 201 Injury Finding; PT Trimmed to $65 - JMP Securities
-
MongoDB, Inc. Files Registration Statement for Proposed Initial Public Offering
-
MongoDB (MDB) Files $100M IPO
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $128 at JMP Securities
-
Adobe (ADBE) PT Raised to $157 at JMP Securities
-
Marinus Pharmaceuticals Announces closing of Public Offering of Common Stock and full exercise of underwriter’s option to purchase additional shares
-
Outreach and Engagio Announce Exclusive Partnership to Deliver the Industry's First Unified Solution for Account-Based Sales and Marketing
-
JMP Securities Downgrades Silver Spring Networks (SSNI) to Market Perform Following Acquisition
-
JMP Securities Starts PJT Partners (PJT) at Market Outperform
-
Cloudera Files Registration Statement for Proposed Follow-on Offering
-
Summit Therapeutics Announces Exercise of Underwriters’ Over-Allotment Option
-
Marinus Pharma (MRNS) Prices 9.33M Common Stock Offering at $3.75/Share
-
Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Marinus Pharmaceuticals (MRNS) to Offer Common Stock
-
Marinus Pharmaceuticals Announces Public Offering of Common Stock
-
Summit Therapeutics plc (SMMT) Prices 1.46M ADS Offering at $12/Sh
-
Summit Therapeutics Announces Pricing of Public Offering of 1,459,000 American Depositary Shares
-
Summit Therapeutics (SMMT) Announces Offering of $15M of ADSs
-
Summit Therapeutics Announces Proposed Public Offering of $15.0 Million of American Depositary Shares
-
Red Hat (RHT): Datapoints From Open Source Summit, Raising PT - JMP
-
Goldman Sachs (GS) Growth Opportunities 'Largely Incremental, Not Transformational' - JMP
-
Marinus Pharmaceuticals (MRNS) PT Raised to $11 at JMP Securities, Positvely Revises EPS Estimate
-
Marinus Pharmaceuticals (MRNS) PT Raised to $11 at JMP Securities
-
Independence Realty Trust, Inc. Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
-
JMP Securities Upgrades Alleghany Corp. (Y) to Market Outperform, Negatively Revises FY 2017/2018 EPS Estimate
-
JMP Securities Starts Savara (SVRA) at Market Outperform
-
Aclaris Therapeutics (ACRS): Bullish KOL Call - JMP
-
Alteryx (AYX) Announces 8M Share Follow-On Offering at $21.25/Sh
-
Alteryx Announces Pricing of Follow-on Public Offering
-
Independence Realty Trust (IRT) Announces 12.5M Share Common Offering at $9.25/Sh
-
Independence Realty Trust, Inc. Announces Pricing of Public Offering of Common Stock
-
Alteryx (AYX) Announces Launch of Follow-on Offering of Common Stock by Selling Holders
-
Alteryx Announces Launch of Proposed Follow-on Offering
-
JMP Securities Starts Energy Recovery (ERII) at Market Outperform
-
JMP Securities Upgrades Sabra Healthcare REIT Inc. (SBRA) to Market Outperform
-
Nutanix (NTNX) PT Raised to $35 at JMP Securities Following 4Q
-
JMP Securities Starts TCF Financial (TCF) at Market Perform
-
JMP Securities Starts Huntington Bancshares (HBAN) at Market Outperform
-
JMP Securities Downgrades Loxo Oncology (LOXO) to Market Perform Citing Valuation
-
A-Mark Precious Metals Closes Acquisition of Goldline International Assets
-
JMP Securities Upgrades Chatham Lodging Trust (CLDT) to Market Outperform
-
Adamas Pharmaceuticals (ADMS) PT Raised to $33 at JMP Securities Following GOCOVRI Approval and Strong Product Label
-
Amazon.com (AMZN) Impresses With Speed - JMP Securities
-
JMP Securities Upgrades Intra-Cellular Therapies (ITCI) to Market Outperform
-
Ultragenyx Pharma (RARE) PT Lowered to $80 at JMP Securities
-
Big Switch Momentum Continues with Triple Digit Growth During Fiscal Year 2017, Fueled By Product Innovation and Geographic Expansion

